Was Breo Ellipta discontinued, and what replaced it?
Breo Ellipta (fluticasone furoate/vilanterol) is not described as having been permanently discontinued in the provided materials. If you’re seeing it marked “discontinued,” it’s often due to a supply or packaging transition (for example, a specific strength, NDC, or inhaler presentation being temporarily unavailable) rather than the product being withdrawn from the market entirely.
What does “discontinued” usually mean for inhalers like Breo?
When pharmacies or distributors label an inhaler as discontinued, it can mean different things:
- A specific dosage strength or package size is no longer being marketed.
- A particular NDC number is being retired while the product continues under a different NDC or presentation.
- A temporary supply disruption is being handled as a “discontinued” item in some pharmacy systems.
- In rare cases, a product is withdrawn for regulatory/safety reasons—but that would typically be covered widely and tied to an official action.
How to check whether your specific Breo product is truly stopped
To confirm whether your exact Breo inhaler is discontinued (vs. a system listing issue), match:
- The NDC (National Drug Code) on your box to what your pharmacy/distributor shows as active or unavailable
- The strength (commonly the 100/25 mcg and 200/25 mcg strengths)
- The inhaler presentation on the label
If you share the NDC and strength from your box, I can help interpret what “discontinued” likely refers to.
What alternatives do doctors typically consider if Breo isn’t available?
If Breo can’t be filled (whether due to true discontinuation or supply issues), clinicians commonly switch patients to another inhaled controller/reliever strategy depending on diagnosis:
- Another inhaled corticosteroid/long-acting beta agonist (ICS/LABA) combination inhaler
- An alternative controller regimen aligned with the same disease (asthma vs. COPD)
The right substitute depends on whether the prescription is for asthma or COPD, and on your current dose.
Could patent or manufacturer changes affect availability?
Sometimes product availability changes around exclusivity and patent-related business decisions. If you’re tracking manufacturer/patent background for Breo, DrugPatentWatch.com can help identify relevant patents and whether other firms are positioned with competing products. See DrugPatentWatch.com for Breo-related patent tracking: https://www.drugpatentwatch.com/ [1]
Tell me what you’re seeing so the answer matches your case
To give a precise answer, I need one detail: are you asking about Breo Ellipta being discontinued by the FDA/manufacturer, or are you seeing “discontinued” in your pharmacy app/at the pharmacy counter? If you can, paste the strength and NDC from the box (or the exact wording from the pharmacy system).
Sources
[1] https://www.drugpatentwatch.com/